NEW YORK–(BUSINESS WIRE)– #AI–Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Queen of Hearts (ACS AI ECG Model). The AI-powered model is designed to identify ECG findings suggestive of urgent acute coronary syndrome (ACS), which can include ST-segment elevation myocardial infarction (STEMI) and STEMI equivalents, and urgently notify clinicians of suspected cases. Heart attack
Month: September 2026
NEW YORK–(BUSINESS WIRE)– #AI–Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Queen of Hearts (ACS AI ECG Model). The AI-powered model is designed to identify ECG findings suggestive of urgent acute coronary syndrome (ACS), which can include ST-segment elevation myocardial infarction (STEMI) and STEMI equivalents, and urgently notify clinicians of suspected cases. Heart attack
LONDON–(BUSINESS WIRE)– DMO-TAS041/3728/002 The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk A12226 15 September 2026 PRESS NOTICE RESULT OF THE SALE BY TENDER OF UP TO £1250 MILLION OF 0½% TREASURY GILT 2029The United Kingdom Debt Management Office (“DMO”) announces that the tender of up to £1,250 million of 0½% Treasury Gilt 2029 (ISIN Code: GB00BLPK7227) has been allocated as follows:(Note: all prices in this notice ar
LONDON–(BUSINESS WIRE)– DMO-TAS041/3728/002 The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk A12226 15 September 2026 PRESS NOTICE RESULT OF THE SALE BY TENDER OF UP TO £1250 MILLION OF 0½% TREASURY GILT 2029The United Kingdom Debt Management Office (“DMO”) announces that the tender of up to £1,250 million of 0½% Treasury Gilt 2029 (ISIN Code: GB00BLPK7227) has been allocated as follows:(Note: all prices in this notice ar
HAMBURG, Deutschland–(BUSINESS WIRE)–Marken und Agenturen buchen ChatGPT Ads ab sofort über Adform und messen sie gemeinsam mit ihren übrigen Kampagnen
HAMBURG, Deutschland–(BUSINESS WIRE)–Marken und Agenturen buchen ChatGPT Ads ab sofort über Adform und messen sie gemeinsam mit ihren übrigen Kampagnen
SEOUL, South Korea–(BUSINESS WIRE)–Genexine, Inc. (KOSDAQ: 095700) announced that Jaehyun Choi, Ph.D., CEO and Head of R&D, presented new preclinical data for GX-BP1, the company’s SOX2-targeting bioPROTAC, at the 2026 World Conference on Lung Cancer (WCLC) in Seoul on September 13. The mini oral presentation, titled ‘Lung-Targeted mRNA-LNP Delivery of SOX2 bioPROTAC: A Comprehensive Strategy for LUAD, LUSC, and SCLC in Monotherapy and Combination Settings’ highlighted the potential of GX
SEOUL, South Korea–(BUSINESS WIRE)–Genexine, Inc. (KOSDAQ: 095700) announced that Jaehyun Choi, Ph.D., CEO and Head of R&D, presented new preclinical data for GX-BP1, the company’s SOX2-targeting bioPROTAC, at the 2026 World Conference on Lung Cancer (WCLC) in Seoul on September 13. The mini oral presentation, titled ‘Lung-Targeted mRNA-LNP Delivery of SOX2 bioPROTAC: A Comprehensive Strategy for LUAD, LUSC, and SCLC in Monotherapy and Combination Settings’ highlighted the potential of GX
LONDEN & MADRID–(BUSINESS WIRE)–Axo Longevity kondigde vandaag de afsluiting aan van een overtekende startkapitaalronde van $5M om zijn lidmaatschap voor preventieve gezondheidszorg in heel Europa uit te breiden. De ronde werd gesteund door MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital en NIAN Sports & Entertainment, samen met angel-investeerders waaronder Dr. Jorge Planas van Clinica Planas Barcelona en Daniel Kulle, voormalig v
LONDEN & MADRID–(BUSINESS WIRE)–Axo Longevity kondigde vandaag de afsluiting aan van een overtekende startkapitaalronde van $5M om zijn lidmaatschap voor preventieve gezondheidszorg in heel Europa uit te breiden. De ronde werd gesteund door MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital en NIAN Sports & Entertainment, samen met angel-investeerders waaronder Dr. Jorge Planas van Clinica Planas Barcelona en Daniel Kulle, voormalig v